Arginine metabolism and nitric oxide bioavailability in sickle cell disease.
Jain
Shilpa
S
Division of Pediatric Hematology-Oncology, Children's Hospital of Pittsburgh, Pittsburgh, PA, USA.
Gladwin
Mark T
MT
D000755:Anemia, Sickle Cell / Q000188:drug therapy* / Q000378:metabolism*; D001120:Arginine / Q000493:pharmacokinetics*; D042783:Endothelial Cells / Q000378:metabolism*; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D009569:Nitric Oxide / Q000378:metabolism*; D052250:Nitric Oxide Synthase Type III / Q000378:metabolism
D006454:Hemoglobins; D009569:Nitric Oxide; D001120:Arginine; C496314:NOS3 protein, human; D052250:Nitric Oxide Synthase Type III